Protocol for generating human CAR-engineered macrophages by Vpx-containing lentivirus
Human-derived macrophages are notoriously difficult to infect with HIV-1-based lentiviruses, posing a limitation to the advancement of chimeric antigen receptor macrophage (CAR-M) therapy. Here, we present a protocol for generating human chimeric antigen receptor (CAR)-engineered macrophages using the viral protein Vpx (encoded by the Sooty Mangabey simian immunodeficiency virus [SIV] and HIV-2 lineages) incorporated into the lentivirus vector, which enhances infection efficiency. We describe steps for cell cultivation, lentivirus production, concentration, infection procedures, and efficiency assessments. This protocol provides a foundation to study macrophage manipulation, especially with CAR or other immune engagers. For complete details on the use and execution of this protocol, please refer to Gao et al.<sup>1</sup>.
Authors
- Yun Gao (ORCID: https://orcid.org/0000-0001-5935-4397)
- Yun Gao (ORCID: https://orcid.org/0000-0002-2086-5218)
- Luo Zhang (ORCID: https://orcid.org/0000-0002-7688-5955)
- Xiaobin Fang (ORCID: https://orcid.org/0000-0001-5852-3646)
Institutions
- Chinese PLA General Hospital (CN)
- Suzhou Research Institute (CN)
Publication Details
- Journal
- STAR Protocols
- Published
- 2024-09-28
- DOI
- https://doi.org/10.1016/j.xpro.2024.103350
- Citations
- 5
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 2.75
Funders
- Innovative Research Group Project of the National Natural Science Foundation of China
- National Natural Science Foundation of China